![]() |
|
|
Vol. 303, Issue 2, 831-839, November 2002
Departments of Neurology and Psychiatry, Johns Hopkins University
School of Medicine, Baltimore, Maryland
The present studies were conducted to further explore the potential
role of metabolic compromise in substituted amphetamine-induced serotonin (5-HT) neurotoxicity. To this end, we examined the
glucoprivic effects of 2-deoxy-D-glucose (2-DG) on the 5-HT
neurotoxic effects of fenfluramine (FEN) and
methylenedioxymethamphetamine (MDMA). Rats were treated with either FEN
or MDMA, alone and in combination, with doses of 2-DG known to produce
glucoprivic effects at either 22 ± 1 or 28 ± 1°C. At
22 ± 1°C, FEN produced hypothermia, MDMA induced hyperthermia,
and both drugs produced significant long-term reductions in regional
brain 5-HT neuronal markers. 2-DG did not enhance 5-HT neurotoxicity
induced by either FEN or MDMA; indeed, in some instances, it afforded
partial neuroprotection. Although 2-DG afforded partial protection from
both FEN and MDMA-induced 5-HT neurotoxic changes, it also caused
significant hypothermia, raising the possibility that protection was
due to a lowered temperature. Increasing the ambient temperature to
28 ± 1°C largely eliminated drug-induced hypothermia and
eliminated the neuroprotective effects of 2-DG. Thus, even
without the confounding effect of temperature, 2-DG still did not
potentiate FEN or MDMA-induced 5-HT neurotoxicity. These findings
suggest that the role of metabolic compromise in amphetamine-induced
5-HT neurotoxicity merits further study.